The study also has a second major finding. It is the first study to show that the chances of having a baby after IVF is closely related to the amount of DNA damage a man has in each of his sperm. A little damage is normal (under 15 per cent per sperm), as is seen in the sperm of fertile men. But if the damage reaches clinically important levels (high sperm DNA damage more than 25 per cent per sperm) it will reduce the couples' chances of a family, even with some forms of fertility treatment.
Using a new IVF technique could considerably increase older women's chances of pregnancy, a small clinical trial presented at a fertility conference suggests.
In the technique embryos produced via IVF are first tested for major genetic abnormalities using a method called comprehensive chromosomal screening (CCS). For this, samples are taken from embryos at the blastocyst stage, when they have around 100 cells.
“Oocyte cryopreservation is an exciting and improving technology, and should no longer be considered experimental. Pregnancy rates and health outcomes of the resulting children are now comparable to those of IVF with fresh eggs,” said Eric Widra, MD, Chair of the Society for Assisted Reproductive Technology (SART) Practice Committee.
"Women aged 66 to 74 years who choose to undergo screening mammography should be screened every two years. They get no added benefit from annual screening, and face almost twice the false positives and biopsy recommendations, which may cause anxiety and inconvenience."
Caffeine consumption during pregnancy is linked to low birth weight babies as well as an overall increase in the length of gestation, reveals new research published in the journal BMC Medicine. Caffeine is able to freely pass the placental barrier in the same way that nutrients or oxygen can. However, an embryo is not able to inactivate the drug properly, which can cause health concerns.
"Excessive uterine bleeding is a common problem we see in gynecological practices and emergency rooms. It can interfere with women's daily activities and put them at risk for anemia and other more serious health consequences caused by blood loss," said Anita L. Nelson, MD, a LA BioMed lead investigator and corresponding author of the study. "Until now, there has been no Food and Drug Administration-approved products for short-term treatment of this condition. Based on our study, we conclude that this new progestogen-only treatment is effective in stopping acute abnormal uterine bleeding."
A syndrome common in women of reproductive age may place them at greater risk for hardening of the arteries, which predisposes them to heart attack and stroke, according to research published Feb. 15 in the American Journal of Physiology, Endocrinology and Metabolism. "We have shown for the first time at the molecular level that the glucose-stimulated inflammation pathways that promote atherosclerosis and a cardiovascular event are already active at an early age in women with polycystic ovary syndrome," Dr. González said.
Women who take folic acid supplements four weeks before becoming pregnant and also during the first weeks of pregnancy have a lower risk of giving birth to children who eventually become diagnosed with an autism spectrum disorder (ASD), Norwegian researchers have reported in JAMA.
Women who reported eating a diet rich in iron were 30 to 40 percent less likely to develop pre-menstrual syndrome (PMS) than women who consumed lower amounts, in a study reported this week by researchers at the University of Massachusetts Amherst School of Public Health and Health Sciences and Harvard. It is one of the first to evaluate whether dietary mineral intake is associated with PMS development.
The grandfather of IVF died last week after bringing bundles of joy to millions of mums and dads who feared they would never have children.
Prof Sir Robert Edwards began working in the field of fertilisation in the 1950s and he and Dr Patrick Steptoe carried out their ground-breaking research in the face of opposition from church leaders, governments and sections of the media, and scepticism from scientific colleagues.